Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Apple
AAPL
|
+$430M |
| 2 |
Microsoft
MSFT
|
+$312M |
| 3 |
Exxon Mobil
XOM
|
+$258M |
| 4 |
GE Aerospace
GE
|
+$224M |
| 5 |
Johnson & Johnson
JNJ
|
+$221M |
Top Sells
| 1 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$58.7M |
| 2 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$57.9M |
| 3 |
CB
CHUBB CORPORATION
CB
|
+$54.7M |
| 4 |
Stellantis
STLA
|
+$26.9M |
| 5 |
GMCR
KEURIG GREEN MTN INC
GMCR
|
+$20M |
Sector Composition
| 1 | Technology | 14.87% |
| 2 | Healthcare | 14.67% |
| 3 | Consumer Discretionary | 10.51% |
| 4 | Consumer Staples | 10.32% |
| 5 | Industrials | 10.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
576
Jones Lang LaSalle
JLL
$14.6B
| $13.2M | 0.02% |
117,100
+35,800
| +44% | +$4.03M |
|
577
RenaissanceRe
RNR
$11.2B
| $13.1M | 0.02% |
113,975
+30,800
| +37% | +$3.54M |
|
578
Alkermes
ALKS
$4.45B
| $12.8M | 0.02% |
389,700
+119,300
| +44% | +$3.91M |
|
|
CPN
579
DELISTED
Calpine Corporation
CPN
| $12.8M | 0.02% |
877,758
+253,000
| +40% | +$3.68M |
|
580
United Therapeutics
UTHR
$17.9B
| $12.7M | 0.02% |
118,700
+36,000
| +44% | +$3.84M |
|
581
Assurant
AIZ
$10.6B
| $12.6M | 0.02% |
171,058
+49,600
| +41% | +$3.67M |
|
|
GRA
582
DELISTED
W.R. Grace & Co.
GRA
| $12.6M | 0.02% |
185,000
+89,100
| +93% | +$6.08M |
|
583
Ingredion
INGR
$8.08B
| $12.5M | 0.02% |
121,400
+25,000
| +26% | +$2.58M |
|
|
SNI
584
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $12.3M | 0.02% |
196,661
+60,400
| +44% | +$3.79M |
|
585
TEGNA Inc
TGNA
$3.37B
| $12.3M | 0.02% |
857,500
+249,062
| +41% | +$3.58M |
|
586
NiSource
NI
$19.2B
| $12.3M | 0.02% |
541,953
+124,264
| +30% | +$2.83M |
|
587
Toll Brothers
TOL
$13.8B
| $12.3M | 0.02% |
435,033
+132,400
| +44% | +$3.74M |
|
|
LPT
588
DELISTED
Liberty Property Trust
LPT
| $12.3M | 0.02% |
383,648
+112,800
| +42% | +$3.62M |
|
589
News Corp Class A
NWSA
$16.2B
| $12.1M | 0.02% |
991,199
+299,700
| +43% | +$3.67M |
|
590
Ionis Pharmaceuticals
IONS
$10.2B
| $12.1M | 0.02% |
312,100
+95,100
| +44% | +$3.69M |
|
|
MBLY
591
DELISTED
Mobileye N.V.
MBLY
| $12M | 0.02% |
336,900
+18,300
| +6% | +$654K |
|
592
Edgewell Personal Care
EPC
$1.01B
| $12M | 0.02% |
155,969
+43,400
| +39% | +$3.35M |
|
|
BEAV
593
DELISTED
B/E Aerospace Inc
BEAV
| $12M | 0.02% |
271,600
+79,400
| +41% | +$3.51M |
|
594
Alnylam Pharmaceuticals
ALNY
$61.5B
| $11.9M | 0.02% |
198,200
+59,900
| +43% | +$3.6M |
|
595
Core Laboratories
CLB
$577M
| $11.9M | 0.02% |
110,000
+32,800
| +42% | +$3.53M |
|
596
Idexx Laboratories
IDXX
$51B
| $11.6M | 0.02% |
153,200
+28,700
| +23% | +$2.17M |
|
597
Broadridge
BR
$29.3B
| $11.6M | 0.02% |
202,300
+43,600
| +27% | +$2.5M |
|
598
Domino's
DPZ
$15.3B
| $11.6M | 0.02% |
90,804
+17,900
| +25% | +$2.28M |
|
|
NUAN
599
DELISTED
Nuance Communications, Inc.
NUAN
| $11.5M | 0.02% |
743,232
+223,492
| +43% | +$3.47M |
|
600
Garmin
GRMN
$45.4B
| $11.4M | 0.02% |
296,648
+89,200
| +43% | +$3.42M |
|